Anticarcinogenic Effects of Dietary Phytoestrogens and Their Chemopreventive Mechanisms

REFERENCES

• Sirtori CR, Arnoldi A, and Johnson SK: Phytoestrogens: End of a tale? Ann Med 37, 423–438, 2005.
   PubMed Web of Science ®Google Scholar
• Adlercreutz H: Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 83, 113–118, 2002.
   PubMed Web of Science ®Google Scholar
• Ursin G, Bernstein L, and Pike MC: Breast cancer. Cancer Surv 19–20, 241–264, 1994.
   PubMedGoogle Scholar
• Van Poppel H and Tombal B: Chemoprevention of prostate cancer with nutrients and supplements. Cancer Manag Res 3, 91–100, 2011.
   PubMedGoogle Scholar
• Adlercreutz H: Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 12, 605–623, 1998.
   PubMed Web of Science ®Google Scholar
• Moon YJ, Wang X, and Morris ME: Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20, 187–210, 2006.
   PubMed Web of Science ®Google Scholar
• Virk-Baker MK, Nagy TR, and Barnes S: Role of phytoestrogens in cancer therapy. Planta Med 76, 1132–1142, 2010.
   PubMed Web of Science ®Google Scholar
• Liu MM, Huang Y, and Wang J: Developing phytoestrogens for breast cancer prevention. Anticancer Agents Med Chem 12, 1306–1313, 2012.
   PubMed Web of Science ®Google Scholar
• Mason JK and Thompson LU: Flaxseed and its lignan and oil components: Can they play a role in reducing the risk of and improving the treatment of breast cancer? Appl Physiol Nutr Metab 39, 663–678, 2014.
   PubMed Web of Science ®Google Scholar
• Charalambous C, Pitta CA, and Constantinou AI: Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC Cancer 13, 238, 2013.
   PubMed Web of Science ®Google Scholar
• Li Y, Meeran SM, Patel SN, Chen H, Hardy TM, et al.: Epigenetic reactivation of estrogen receptor-alpha (ERalpha) by genistein enhances hormonal therapy sensitivity in ERalpha-negative breast cancer. Mol Cancer 12, 9, 2013.
   PubMed Web of Science ®Google Scholar
• Lindahl G, Saarinen N, Abrahamsson A, and Dabrosin C: Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer. Cancer Res 71, 51–60, 2011.
   PubMed Web of Science ®Google Scholar
• Mishra R, Bhadauria S, Murthy PK, and Murthy PS: Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenz[alpha]anthracene-induced rat mammary tumor model. Food Chem Toxicol 49, 434–440, 2011.
   PubMed Web of Science ®Google Scholar
• Shu XO, Zheng Y, Cai H, Gu K, Chen Z, et al.: Soy food intake and breast cancer survival. Jama 302, 2437–2443, 2009.
   PubMed Web of Science ®Google Scholar
• Kang X, Zhang Q, Wang S, Huang X, and Jin S: Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. Cmaj 182, 1857–1862, 2010.
   PubMed Web of Science ®Google Scholar
• Perabo FG, Von Low EC, Ellinger J, von Rucker A, Muller SC, et al.: Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 11, 6–12, 2008.
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, et al.: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252–4263, 1998.
   PubMed Web of Science ®Google Scholar
• Pelekanou V and Leclercq G: Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis. Int J Dev Biol 55, 869–878, 2011.
   PubMed Web of Science ®Google Scholar
• Whitten PL and Patisaul HB: Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect 109(Suppl 1), 5–20, 2001.
   PubMed Web of Science ®Google Scholar
• Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, et al.: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451–1457, 1996.
   PubMed Web of Science ®Google Scholar
• Hwang KA, Kang NH, Yi BR, Lee HR, Park MA, et al.: Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17beta-estradiol or bisphenol A via the inhibition of cell cycle progression. Int J Oncol 42, 733–740, 2012.
   PubMed Web of Science ®Google Scholar
• Hwang KA, Park MA, Kang NH, Yi BR, Hyun SH, et al.: Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 beta-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways. Toxicol Appl Pharmacol 272, 637–646, 2013.
   PubMed Web of Science ®Google Scholar
• Singh AV, Franke AA, Blackburn GL, and Zhou JR: Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 66, 1851–1858, 2006.
   PubMed Web of Science ®Google Scholar
• Sasamura H, Takahashi A, Miyao N, Yanase M, Masumori N, et al.: Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma. Br J Cancer 86, 768–773, 2002.
   PubMed Web of Science ®Google Scholar
• Farina HG, Pomies M, Alonso DF, and Gomez DE: Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 16, 885–891, 2006.
   PubMed Web of Science ®Google Scholar
• Connolly JM, Liu XH, and Rose DP: Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. Nutr Cancer 29, 48–54, 1997.
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, et al.: Genistein chemoprevention: Timing and mechanisms of action in murine mammary and prostate. J Nutr 132, 552S–558S, 2002.
   PubMed Web of Science ®Google Scholar
• Peterson G: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125, 784S–789S, 1995.
   PubMed Web of Science ®Google Scholar
• Bhuva HA and Kini SG: Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors. J Mol Graph Model 29, 32–37, 2010.
   PubMed Web of Science ®Google Scholar
• Piontek M, Hengels KJ, Porschen R, and Strohmeyer G: Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. Anticancer Res 13, 2119–2123, 1993.
   PubMed Web of Science ®Google Scholar
• Shao Z, Wu J, and Shen Z: [Genistein exerts multiple suppressive effects on human breast carcinoma cells]. Zhonghua Zhong Liu Za Zhi 22, 362–365, 2000.
   PubMedGoogle Scholar
• Wei H, Bowen R, Zhang X, and Lebwohl M: Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis 19, 1509–1514, 1998.
   PubMed Web of Science ®Google Scholar
• Dean NM, Kanemitsu M, and Boynton AL: Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem Biophys Res Commun 165, 795–801, 1989.
   PubMed Web of Science ®Google Scholar
• Peterson G, Barnes S: Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179, 661–667, 1991.
   PubMed Web of Science ®Google Scholar
• Zhou N, Yan Y, Li W, Wang Y, Zheng L, et al.: Genistein inhibition of topoisomerase IIalpha expression participated by Sp1 and Sp3 in HeLa cell. Int J Mol Sci 10, 3255–3268, 2009.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA: Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? Biochem Pharmacol 42, 2253–2258, 1991.
   PubMed Web of Science ®Google Scholar
• Mizushina Y, Shiomi K, Kuriyama I, Takahashi Y, and Yoshida H: Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation. Int J Oncol 43, 1117–1124, 2013.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, et al.: Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer 99, 846–852, 2002.
   PubMed Web of Science ®Google Scholar
• Akimaru K, Utsumi T, Sato EF, Klostergaard J, Inoue M, et al.: Role of tyrosyl phosphorylation in neutrophil priming by tumor necrosis factor-alpha and granulocyte colony stimulating factor. Arch Biochem Biophys 298, 703–709, 1992.
   PubMed Web of Science ®Google Scholar
• Tanimura M, Kobuchi H, Utsumi T, Yoshioka T, Kataoka S, et al.: Neutrophil priming by granulocyte colony stimulating factor and its modulation by protein kinase inhibitors. Biochem Pharmacol 44, 1045–1052, 1992.
   PubMed Web of Science ®Google Scholar
• Wei H, Wei L, Frenkel K, Bowen R, and Barnes S: Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20, 1–12, 1993.
   PubMed Web of Science ®Google Scholar
• Chen FP and Chien MH: Phytoestrogens induce apoptosis through a mitochondria/caspase-pathway in human breast cancer cells. Climacteric 17, 385–392, 2014.
   PubMed Web of Science ®Google Scholar
• Wietrzyk J, Grynkiewicz G, and Opolski A: Phytoestrogens in cancer prevention and therapy–mechanisms of their biological activity. Anticancer Res 25, 2357–2366, 2005.
   PubMed Web of Science ®Google Scholar
• Day JK, Bauer AM, DesBordes C, Zhuang Y, Kim BE, et al.: Genistein alters methylation patterns in mice. J Nutr 132, 2419S–2423S, 2002.
   PubMed Web of Science ®Google Scholar
• Esteller M: Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 96(Suppl.), R26–R30, 2007.
   PubMed Web of Science ®Google Scholar
• Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, et al.: Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 68, 2736–2744, 2008.
   PubMed Web of Science ®Google Scholar
• Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, et al.: Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 123, 552–560, 2008.
   PubMed Web of Science ®Google Scholar
• Zhao R, Xiang N, Domann FE, and Zhong W: Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutr Cancer 61, 397–407, 2009.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Li Y, Wang Z, and Sarkar FH: Multi-targeted therapy of cancer by genistein. Cancer Lett 269, 226–242, 2008.
   PubMed Web of Science ®Google Scholar
• Lee J, Ju J, Park S, Hong SJ, and Yoon S: Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of beta-catenin signaling in hormone refractory PC-3 prostate cancer cells. Nutr Cancer 64, 153–162, 2012.
   PubMed Web of Science ®Google Scholar
• Guo JM, Xiao BX, Dai DJ, Liu Q, and Ma HH: Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro. World J Gastroenterol 10, 860–863, 2004.
   PubMed Web of Science ®Google Scholar
• Guo JM, Xiao BX, Liu DH, Grant M, Zhang S, et al.: Biphasic effect of daidzein on cell growth of human colon cancer cells. Food Chem Toxicol 42, 1641–1646, 2004.
   PubMed Web of Science ®Google Scholar
• Gercel-Taylor C, Feitelson AK, and Taylor DD: Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res 24, 795–800, 2004.
   PubMed Web of Science ®Google Scholar
• Choi EJ and Kim GH: Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine 15, 683–690, 2008.
   PubMed Web of Science ®Google Scholar
• Dong X, Xu W, Sikes RA, and Wu C: Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells. Food Chem 135, 1643–1652, 2012.
   PubMed Web of Science ®Google Scholar
• Szliszka E and Krol W: Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells. Oncol Rep 26, 533–541, 2011.
   PubMed Web of Science ®Google Scholar
• Singh-Gupta V, Zhang H, Yunker CK, Ahmad Z, Zwier D, et al.: Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy. Pharm Res 27, 1115–1127, 2010.
   PubMed Web of Science ®Google Scholar
• Magee PJ: Is equol production beneficial to health? Proc Nutr Soc 70, 10–18, 2011.
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Masumori N, Fukuta F, Yoneta A, Hida T, et al.: Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev 14, 1–4, 2013.
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, and Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577–3584, 2002.
   PubMed Web of Science ®Google Scholar
• Song KB, Atkinson C, Frankenfeld CL, Jokela T, Wahala K, et al.: Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 136, 1347–1351, 2006.
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhang Y, Ma D, Shi Y, Liu C, et al.: (+/−)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity. J Clin Biochem Nutr 51, 61–67, 2012.
   PubMed Web of Science ®Google Scholar
• Choi EJ and Kim T: Daidzein modulates induction of hepatic CYP1A1, 1B1, and AhR by 7,12-dimethylbenz[a]anthracene in mice. Arch Pharm Res 31, 1115–1119, 2008.
   PubMed Web of Science ®Google Scholar
• Jing Y, Nakaya K, and Han R: Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo. Anticancer Res 13, 1049–1054, 1993.
   PubMed Web of Science ®Google Scholar
• Constantinou AI, Lantvit D, Hawthorne M, Xu X, van Breemen RB, et al.: Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer 41, 75–81, 2001.
   PubMed Web of Science ®Google Scholar
• Jin Z and MacDonald RS: Soy isoflavones increase latency of spontaneous mammary tumors in mice. J Nutr 132, 3186–3190, 2002.
   PubMed Web of Science ®Google Scholar
• Jin S, Zhang QY, Kang XM, Wang JX, and Zhao WH: Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann Oncol 21, 263–268, 2010.
   PubMed Web of Science ®Google Scholar
• Li M, Kondo T, Zhao QL, Li FJ, Tanabe K, et al.: Apoptosis induced by cadmium in human lymphoma U937 cells through Ca2+-calpain and caspase-mitochondria- dependent pathways. J Biol Chem 275, 39702–39709, 2000.
   PubMed Web of Science ®Google Scholar
• Androutsopoulos VP, Spyrou I, Ploumidis A, Papalampros AE, Kyriakakis M, et al.: Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors. PLoS One 8, e82487, 2013.
   PubMed Web of Science ®Google Scholar
• Russo P, Del Bufalo A, and Cesario A: Flavonoids acting on DNA topoisomerases: recent advances and future perspectives in cancer therapy. Curr Med Chem 19, 5287–5293, 2012.
   PubMed Web of Science ®Google Scholar
• Athar M, Back JH, Tang X, Kim KH, Kopelovich L, et al.: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224, 274–283, 2007.
   PubMed Web of Science ®Google Scholar
• Baur JA and Sinclair DA: Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5, 493–506, 2006.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Levenson AS, and Biswas PK: Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha. BMC Struct Biol 13, 27, 2013.
   Web of Science ®Google Scholar
• Cimino S, Sortino G, Favilla V, Castelli T, Madonia M, et al.: Polyphenols: Key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev 2012, 632959, 2012.
   PubMed Web of Science ®Google Scholar
• Marcsek ZL, Kocsis Z, Szende B, Tompa A: Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells. Cell Biol Int 31, 1214–1219, 2007.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Mukhtar H, and Ahmad N: Resveratrol imparts photoprotection of normal cells and enhances the efficacy of radiation therapy in cancer cells. Photochem Photobiol 84, 415–421, 2008.
   PubMed Web of Science ®Google Scholar
• Baarine M, Thandapilly SJ, Louis XL, Mazue F, Yu L, et al.: Pro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cells. Genes Nutr 6, 161–169, 2011.
   PubMed Web of Science ®Google Scholar
• Ulasli SS, Celik S, Gunay E, Ozdemir M, Hazman O, et al.: Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene. Asian Pac J Cancer Prev 14, 6159–6164, 2013.
   PubMed Web of Science ®Google Scholar
• Chen FP and Chien MH: Phytoestrogens induce apoptosis through a mitochondria/caspase-pathway in human breast cancer cells. Climacteric, 17, 385-392, 2014.
   Web of Science ®Google Scholar
• Kang NH, Hwang KA, Kim TH, Hyun SH, Jeung EB, et al.: Induced growth of BG-1 ovarian cancer cells by 17beta-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression. Mol Med Rep 6, 151–156, 2012.
   PubMed Web of Science ®Google Scholar
• Kang NH, Hwang KA, Lee HR, Choi DW, and Choi KC: Resveratrol regulates the cell viability promoted by 17beta-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor alpha and insulin growth factor-1 receptor in BG-1 ovarian cancer cells. Food Chem Toxicol 59, 373–379, 2013.
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218–220, 1997.
   PubMed Web of Science ®Google Scholar
• Yin HT, Tian QZ, Guan L, Zhou Y, Huang XE, et al.: In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev 14, 1703–1706, 2013.
   PubMed Web of Science ®Google Scholar
• Li K, Dias SJ, Rimando AM, Dhar S, Mizuno CS, et al.: Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PLoS One 8, e57542, 2013.
   PubMed Web of Science ®Google Scholar
• Guo L, Peng Y, Yao J, Sui L, Gu A, et al.: Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice. Cancer Biother Radiopharm 25, 471–477, 2010.
   PubMed Web of Science ®Google Scholar
• Ratan HL, Steward WP, Gescher AJ, and Mellon JK: Resveratrol–a prostate cancer chemopreventive agent? Urol Oncol 7, 223–227, 2002.
   PubMed Web of Science ®Google Scholar
• Athar M, Back JH, Kopelovich L, Bickers DR, and Kim AL: Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys 486, 95–102, 2009.
   PubMed Web of Science ®Google Scholar
• Ferraz da Costa DC, Casanova FA, Quarti J, Malheiros MS, Sanches D, et al.: Transient transfection of a wild-type p53 gene triggers resveratrol-induced apoptosis in cancer cells. PLoS One 7, e48746, 2012.
   PubMed Web of Science ®Google Scholar
• Leiro J, Arranz JA, Fraiz N, Sanmartin ML, Quezada E, et al.: Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling. Int Immunopharmacol 5, 393–406, 2005.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kannappan R, Reuter S, Kim JH, and Aggarwal BB: Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci 1215, 150–160, 2011.
   PubMed Web of Science ®Google Scholar
• Chun YJ, Kim MY, and Guengerich FP: Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262, 20–24, 1999.
   PubMed Web of Science ®Google Scholar
• Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, and Castellon EA: Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 28, 282–293, 2007.
   PubMed Web of Science ®Google Scholar
• Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, et al.: Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5, 2034–2042, 2006.
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Zhu T, Parray A, Siddique HR, Yang W, et al.: Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor. PLoS One 8, e78479, 2013.
   PubMed Web of Science ®Google Scholar
• Magee PJ and Rowland IR: Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91, 513–531, 2004.
   PubMed Web of Science ®Google Scholar
• Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, et al.: Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10, 127–135, 2000.
   PubMedGoogle Scholar
• Carter LG, D'Orazio JA, and Pearson KJ: Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 21, R209–R25, 2014.
   PubMed Web of Science ®Google Scholar
• Dong X, Xu W, Sikes RA, and Wu C: Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Food Chem 141, 1923–1933, 2013.
   PubMed Web of Science ®Google Scholar